INO vs MSFT: Which Stock is Better?
Side-by-side comparison of Inovio Pharmaceuticals Inc and Microsoft Corp in 2026
INO
Inovio Pharmaceuticals Inc
$1.09
MSFT
Microsoft Corp
$387.00
Key Metrics Comparison
| Metric | INO | MSFT | Winner |
|---|---|---|---|
| Market Cap | $86.49M | N/A | INO |
| P/E Ratio | N/A | 23.21 | MSFT |
| EPS (TTM) | $N/A | $15.98 | MSFT |
| Revenue Growth | -1.0% | 0.2% | MSFT |
| Gross Margin | -82857.4% | 68.6% | MSFT |
Analyze INO
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INO or MSFT a better investment?
Comparing INO and MSFT: Inovio Pharmaceuticals Inc has a market cap of $86.49M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INO and MSFT?
INO (Inovio Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INO or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INO or MSFT?
MSFT has higher revenue growth at 0.2% vs -1.0% for INO.
Which company is more profitable: INO or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to -82857.4% for INO.
Which is the larger company: INO or MSFT?
Inovio Pharmaceuticals Inc (INO) is larger with a market cap of $86.49M compared to N/A for MSFT.
Should I buy INO or MSFT in 2026?
Both INO and MSFT have investment merit. INO trades at $1.09 while MSFT trades at $387.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INO and MSFT stock?
Key differences: Market Cap ($86.49M vs N/A), P/E Ratio (N/A vs 23.2x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (-82857.4% vs 68.6%).